These discussions focused on gaps in artificial intelligence, community-based advanced therapy, and demands of federal drug price negotiations.
Ella Hohmann
Advertisement
Articles by Ella Hohmann
Pharmacy benefit manager reforms, gene therapy scale-up, artificial trust risks, and more reshape specialty pharmacy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Some Providers Prescribe Unapproved Retatrutide for Weight Loss at Alarming Rate
2
A Practical Guide for Pharmacy Drug Shortages
3
The Role of the Pharmacist in Health Disparities in Cardiometabolic Disease
4
Payer Preference Shifts Toward Unbundled, Transparent PBM Models
5